Creative Touch Permanent Makeup and Aesthetics

Glycolic acid is the smallest alpha-hydroxy acid molecule (MW 76 Da), a property that historically shaped its reputation as the AHA that penetrates most readily into skin. Its primary mechanism in the stratum corneum is disruption of corneodesmosomes – the protein structures that hold corneocytes in cohesion – accelerating desquamation and thinning the stratum corneum to improve surface texture. A second, structurally distinct mechanism operates in the viable epidermis and dermis: glycolic acid stimulates keratinocytes to release paracrine signals, including IL-1α, that indirectly drive fibroblast collagen synthesis. At cosmetic concentrations (8–15%) adjusted to pH 4, glycolic acid produces measurable 5–6% increases in total collagen without fibroblast penetration and without increasing the pro-inflammatory marker TNF-α. A third mechanism – direct inhibition of tyrosinase enzyme activity in melanocytes, independent of pH – explains glycolic acid’s efficacy against hyperpigmentation beyond simple accelerated turnover. These three mechanisms together, operating at different tissue depths, make glycolic acid one of the most multi-dimensional topical actives in a skincare routine. The significant counterbalance is a well-documented increase in UV sensitivity that makes robust sun protection non-negotiable rather than recommended.

Glycolic acid is an alpha-hydroxy acid (AHA) naturally occurring in sugar cane, with a two-carbon molecular structure that gives it the smallest molecular weight of all clinically used AHAs (76 Da). This small size has often been described as the mechanism behind its greater skin penetration compared to larger AHAs such as lactic acid (90 Da) or mandelic acid (152 Da). ^[4] The relationship between molecular size and penetration is real but not the complete picture – formulation pH and vehicle play as significant a role in delivery as molecular weight, and a well-formulated lactic acid preparation at equivalent pH will penetrate comparably. What the small molecule size does confer is a greater free acid fraction at equivalent pH, which produces a more aggressive corneodesmosome disruption effect per percentage concentration compared to larger-molecule AHAs.

The Exfoliation Mechanism: Corneodesmosome Disruption

Glycolic acid does not dissolve skin cells – it disrupts the specific protein structures that hold them in cohesion. The stratum corneum is organised into two zones: the stratum compactum (lower layers, where cells are tightly bound) and the stratum disjunctum (upper layers, where desquamation is progressively occurring). Glycolic acid’s exfoliation action is targeted to the stratum disjunctum – biopsy studies confirm that enhanced desmosomal breakdown occurs in this upper zone whilst desmosomes in the stratum compactum remain unaffected. ^[1] The specific target is corneodesmosin (CDSN) – an extracellular glycoprotein component of the corneodesmosome structure. At glycolic acid concentrations of 8–15% at pH 4, CDSN expression is significantly reduced, with the lowest levels at 10% concentration. ^[2]

The timing of this mechanism involves two distinct phases. Acutely (within 30 minutes of application), glycolic acid activates cathepsin D (CD) – a protease that degrades corneodesmosome proteins – through pH-mediated activation at the lower stratum corneum layers. Over the subsequent days to weeks, glycolic acid separately enhances de novo CD production in the stratum corneum, sustaining the desquamation-promoting effect beyond the window of active acid presence. This two-phase mechanism explains why cumulative use produces progressively improving texture that a single application does not achieve.

The 25% Paradox

A clinically relevant finding from concentration-response research deserves explicit attention: at 25% glycolic acid (pH 4), CDSN levels actually increased by 36.7% relative to untreated skin. ^[2] This counter-intuitive barrier-reinforcing response at high concentration – where the stratum corneum appears to mount a compensatory upregulation of corneodesmosome proteins – suggests the dose-response relationship is not linear and that very high concentrations may trigger barrier defence responses rather than simply amplifying exfoliation. This is one of the mechanistic reasons that periodic professional-strength glycolic acid peels produce different effects than daily high-concentration home use: they operate through an acute acid-exposure response followed by complete recovery, rather than a sustained sub-threshold disruption.

The Collagen Mechanism: Indirect Paracrine Signalling

The conventional description of glycolic acid as a collagen stimulator is accurate but mechanistically incomplete in most consumer skincare communications. At cosmetic-use concentrations (8–15%), glycolic acid does not penetrate into the dermis in quantities sufficient to directly stimulate fibroblast activity. The collagen synthesis it produces operates through a paracrine relay: glycolic acid activates keratinocytes, which release IL-1α and other keratinocyte-derived factors into the surrounding tissue; these paracrine signals then stimulate adjacent dermal fibroblasts to increase collagen synthesis. ^[3]

The same IL-1α release simultaneously modulates MMP-driven matrix degradation – GA treatment affects both the synthesis and degradation sides of the collagen balance through this keratinocyte intermediary. ^[3] The net result at 8–15% concentration (pH 4) is a measurable 5–6% increase in total collagen across all tested concentrations – modest but statistically significant and achieved without TNF-α upregulation, confirming the collagen stimulus occurs without a parallel pro-inflammatory signal. ^[2] Glycolic acid also increases both epidermal and dermal hyaluronic acid levels and improves the quality of elastic fibres – effects that follow from the combined keratinocyte activation and stratum corneum renewal rather than from a single isolated mechanism. ^[2]

The Hyperpigmentation Mechanism: Tyrosinase Inhibition

Glycolic acid’s efficacy against hyperpigmentation – melasma, solar lentigines, post-inflammatory hyperpigmentation – is most commonly attributed to accelerated epidermal turnover that disperses accumulated melanin more rapidly. This mechanism is real, but it is not the complete picture. In vitro evidence confirms that glycolic acid directly inhibits tyrosinase enzyme activity in melanocytes in a dose-dependent manner, without affecting tyrosinase mRNA expression, protein expression, or cell growth. ^[6] This direct tyrosinase inhibition is independent of its acidic nature – it is a specific molecular property of glycolic acid, not simply a consequence of acidic pH reducing melanocyte function.

The clinical implication is that glycolic acid acts on hyperpigmentation through two distinct pathways simultaneously: accelerated melanin dispersal through epidermal turnover, and reduced melanin synthesis through direct tyrosinase activity inhibition. This two-pathway mechanism is the reason glycolic acid performs better against hyperpigmentation than a simple physical exfoliant at equivalent turnover rates, and the reason AHA-based treatments for melasma show pigmentation improvement beyond what exfoliation alone would produce.

pH, Concentration, and the Formulation Science

The activity of glycolic acid is inseparable from its pH. The key threshold: formulations above pH 4 progressively lose efficacy, and the suggestion in the research literature is that above pH 4 the exfoliating and collagen-stimulating effects are significantly diminished. Below pH 3.5, with high free acid concentration, glycolic acid readily disrupts corneocyte barrier structures – producing irritation and potentially impairing the barrier function it is intended to improve at lower concentrations. ^[2]

pH 4 is the formulation sweet spot – producing effective corneodesmosome disruption and keratinocyte-mediated collagen stimulation whilst avoiding both the irritation of very low pH and the inactivity of partially neutralised products. Professional chemical peels typically operate at pH 1.5–3.5 at concentrations of 30–70%, producing acute ablative effects through frank acid disruption; they are categorically different interventions from cosmetic-use formulations, operating at a different point on the concentration-pH matrix.

UV Sensitisation

UV sensitisation is one of the most clinically significant properties of glycolic acid and the one most commonly underemphasised in consumer product communication. Topical glycolic acid (10%) applied over three to four weeks measurably increases UV sensitivity – reducing the minimal erythemal dose (MED) for UVB, increasing UVB-induced erythema and tanning, and enhancing UVA-induced tanning. ^[5] The thinned stratum corneum following glycolic acid use provides less physical UV attenuation – fewer corneocyte layers means reduced scattering and absorption of UV radiation before it reaches the viable epidermis. This is not a rare or theoretical risk: it is a consistent finding across multiple studies.

This has direct practical consequences in treatment sequencing. In clients using glycolic acid as part of a skincare routine alongside treatments such as FTL, RF microneedling, or chemical peels, active glycolic acid use in the days immediately before treatment increases baseline UV sensitivity at a point where post-treatment skin is already more vulnerable. The recommendation is not to avoid glycolic acid long-term but to pause use in the week before energy-based treatments and to ensure SPF50 is non-negotiable throughout any glycolic acid course – particularly for FST IV–VI clients where the combined UV sensitisation and post-inflammatory hyperpigmentation risk is highest.